Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.

Background Elevated levels of C-reactive protein, even in the absence of hyperlipidemia, are associated with an increased risk of coronary events. Statin therapy reduces the level of C-reactive protein independently of its effect on lipid levels. We hypothesized that statins might prevent coronary e... View More